HomeCare February 24, 2025
The proposed rule would establish special registrations for remote prescribing of controlled substances without requiring an in-person visit
WASHINGTON—ATA Action, the advocacy arm of the American Telemedicine Association, submitted concerns and detailed recommendations on the Drug Enforcement Administration (DEA)’s proposed rule to establish special registrations for the remote prescribing of controlled substances without requiring an in-person visit.
ATA Action said while many aspects of the rule are workable for the telehealth community, without meaningful changes, significant gaps will remain, leaving too many patients without access to necessary care.
“ATA Action is a longtime advocate for a special registration process and recognizes the need to balance expanded patient access with necessary safeguards,” said Kyle Zebley, senior vice president of...
Today's Sponsors
Today's Sponsor